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OBJECTIVE: The primary care visit represents an
important venue for intervening with a large population
of smokers. However, physician adherence to the
Smoking Cessation Clinical Guideline (5As) remains
low. We evaluated the effectiveness of a computer-
tailored intervention designed to increase smoking
cessation counseling by primary care physicians.
METHODS: Physicians and their patients were ran-
domized to either intervention or control conditions. In
addition to brief smoking cessation training, interven-
tion physicians and patients received a one-page report
that characterized the patients’ smoking habit and
history and offered tailored recommendations. Physi-
cian performance of the 5As was assessed via patient
exit interviews. Quit rates and smoking behaviors were
assessed 6 months postintervention via patient phone
interviews. Intervention effects were tested in a sample
of 70 physicians and 518 of their patients. Results were
analyzed via generalized and mixed linear modeling
controlling for clustering.
MEASUREMENTS AND MAIN RESULTS: Intervention
physicians exceeded controls on “Assess” (OR 5.06; 95%
CI 3.22, 7.95), “Advise” (OR 2.79; 95% CI 1.70, 4.59),
“Assist–set goals” (OR 4.31; 95% CI 2.59, 7.16), “Assist–
provide written materials” (OR 5.14; 95% CI 2.60,
10.14), “Assist–provide referral” (OR 6.48; 95% CI 3.11,
13.49), “Assist–discuss medication” (OR 4.72;95% CI
2.90, 7.68), and “Arrange” (OR 8.14; 95% CI 3.98,
16.68), all p values being <0.0001. Intervention patients
were 1.77 (CI 0.94, 3.34,p=0.078) times more likely than
controls to be abstinent (12 versus 8%), a difference that
approached, but did not reach statistical significance,
and surpassed controls on number of days quit (18.4
versus 12.2, p<.05) but not on number of quit attempts.
CONCLUSIONS: The use of a brief computer-tailored
report improved physicians’ implementation of the 5As
and had a modest effect on patients’ smoking behaviors
6 months postintervention.
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D
espite steady decline in the United States smoking
prevalence over the past decade, roughly 45 million
adults continue to smoke. Tobacco use remains the leading
preventable cause of morbidity and mortality.
1 Although
advances in high-intensity, clinic-based interventions have
yielded moderate to high abstinence rates, such treatments
reach few smokers. To reach a larger spectrum of smokers,
effective low-intensity interventions are needed.
The Public Health Service Clinical Practice Guideline on
Tobacco Use and Dependence
2 acknowledges the unique role
health care providers play in promoting smoking cessation
efforts by a large number of smokers in the community. The
Guideline recommends that in every visit, physicians perform
5As: ask about smoking status; advise smokers to quit; assess
readiness toquit; assist inquitting; andarrange follow-up. Over
70% of smokers see a physician annually,
3 making the medical
visit a critical “teachable moment” for delivery of smoking
cessation messages. Even brief interventions delivered by pri-
mary care physicians have been shown to increase cessation.
4,5
Despite the potential impact, data indicate that few smokers
are offered smoking cessation assistance during routine
medical visits.
6–8 A medical chart review study revealed that
only 21% of physicians provided smoking cessation counsel-
ing, and only 1.3% regularly recommended nicotine replace-
ment therapy.
9 Patient reports also yield a low rate of physician
delivery of smoking cessation services. One statewide survey
documented that 51% of smokers were asked about smoking;
45.5% were advised to quit; 14.9% were offered assistance to
quit; and 3% were scheduled for smoking-related follow-up.
10
Incorporating smoking cessation counseling into medical
practice remains a challenge.
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478Technology offers another promising approach that has the
potential to extend the reach of interventions that could
otherwise only be offered by experienced clinicians. An expert
system is a computer program that implements decisional
algorithms similar to those an experienced clinician might
practice. A system based on the stage-of-readiness framework
evaluates an individual’s smoking history and provides a
personalized feedback report with counseling messages tai-
lored to the smoker’s readiness for change. Results from
several studies indicate that providing smokers with a person-
alized, stage-based report enhances cessation rates.
11–17
In the current study, we tested an intervention that inte-
grates a brief, tailored expert-system report with face-to-face
physician-delivered counselingi nap r i m a r yc a r es e t t i n g .
Based on patients’ assessment responses, a tailored report
was generated and distributed to physicians and their patients
who smoke. The current intervention was innovative in several
ways. Unlike previous computer-tailored interventions that
were directed toward patients only, the current intervention
targeted both patients and physicians in “real time” during the
medical visit. Also, to maximize its use in the time-strapped
primary care environment, the tailored report was consider-
ably shorter than the previously tested versions. The interven-
tion had two objectives: (1) to bolster the rate at which
physicians delivered smoking cessation services and (2) to
increase patients’ quit rates. Providing both the smoker and
his/her physician with a report at the time of the health care
visit was expected to cue physicians to deliver smoking
cessation counseling as well as activate patients to elicit such
counseling. In addition to its cuing function, the report was
intended to compensate for limitations in physician time and
knowledge of counseling techniques, thus bolstering treatment
capacity. We hypothesized that the intervention would surpass
usual care on physician implementation of the 5As, quit rate,
length of quit attempts, number of quit attempts, and stage-of-
change progression.
METHODS
Study Design and Recruitment
A randomized controlled trial was conducted to examine the
effectiveness of a tailored smoking cessation intervention
directed toward physicians and patients during a routine
office visit. In partnership with a leading New York City
(NYC)-managed care organization, we identified potentially
eligible physicians in the four largest metropolitan boroughs,
Bronx, Brooklyn, Manhattan, and Queens. The boroughs
were divided into different geographic areas, and physicians
were sampled from each area to ensure geographic repre-
sentation.
The study was approved by the institutional review board.
All participants underwent an informed consent process.
Physician recruitment was initiated via facsimile invitation
followed by telephone calls from a physician recruiter.
Physicians who consented to participate were contacted by
the study director and screened for eligibility. Eligibility
criteria included internal or family medicine specialty, plans
to continue practicing in current location for at least 1 year,
at least 75 patient visits per week, primarily English-
speaking patients, and fewer than 25% geriatric patients.
All physicians were paid $150. Physicians in the interven-
tion condition received an additional $50 in recognition of
greater time commitments expected of them. A random
number generator was used to assign physicians to inter-
vention or usual care control. Physicians learned their group
assignment after signing the informed consent. Physician
recruitment occurred between September 2002 and May
2004. Of the total 579 physicians contacted by facsimile, 70
were successfully recruited and completed the study (see
flowchart, Fig. 1).
Project staff screened patients in physicians’ waiting rooms.
All identified smokers were offered the opportunity to partic-
ipate. Study staff continued to recruit at each physician office
f o ru pt o1 0d a y so ru n t i l1 0s m o k e r sw e r ee n r o l l e d ,
whichever came first. Initial assessment was completed
immediately before the patient’s appointment and included
information necessary to generate the report. The second
assessment occurred immediately after the medical visit and
contained questions regarding the physician’s5 Ap e r f o r -
mance. Patients in the usual care condition completed the
same assessments but did not receive the report. Patients
were contacted 6 months after the initial enrollment for a
telephone follow-up interview to assess outcomes. Self-
reported abstinence was biochemically validated with the use
of a saliva–cotinine test.
Smokers were paid $20 for completing initial assessments
and $10 for the follow-up interview. To be eligible, smokers
were required to be at least 18 years old, to have smoked in
the past 7 days, and to have smoked more than 100 cigarettes
in their lifetime. Participants were also required to be English-
speaking and to plan to retain their physician for the next
12 months. Of the total 5,826 smokers and nonsmokers
screened, 580 met eligibility criteria and agreed to participate.
Sixty-two were withdrawn due to computer malfunction,
scheduling, or time constraint. A total of 518 smokers complet-
ed initial assessments; 465 completed the 6-month assessment
(see Fig. 1).
Initial Patient Assessment
Several measures were used to tailor the expert-system
report. The Contemplation Ladder assessed readiness to
quit
18,19 based on the stages identified by Prochaska and
DiClemente.
20 Patients were classified into: precontemplation
(not considering quitting at all), contemplation (considering
quitting in the next 6 months), preparation (planning to quit
in the next 30 days), and action (recently quit smoking). The
Fagerstrom Test for Nicotine Dependence
21,22 was used to
measure dependence level. The Pros and Cons Scale was used
to identify perceived positive and negative features associated
with smoking.
23 The Self-Efficacy Scale identified main temp-
tations to smoke and measured patients’ confidence to not
smoke in specific situations.
24 Additional information used to
tailor the report included smoking quantity and duration,
past quit attempt duration, and existing medical conditions
exacerbated by smoking.
Smoking Cessation Expert-System Intervention
A health educator provided individual physician training in
brief smoking cessation counseling based on the 5As Clinical
479 Unrod et al.: Smoking Cessation Intervention by Primary Care Physicians JGIMPractice Guideline. The training was conducted during a 40-
minute visit to the physician’so f f i c ea n df o l l o w e da n
“academic detailing” approach.
25 The educator explained
the use of the report and encouraged physicians to review it
witheachpatientenrolledinthestudy.Physiciansinthecontrol
condition were not given any training and were instructed to
continue their usual smoking cessation practices.
The report contained smoking-related information and
recommendations based on the information provided during
the patient assessment (see Fig. 2 for sample). To minimize
time burden and maximize user friendliness, the patient
assessment lasted for 5–10 minutes, and the report was one
page. Patients entered their information directly into a laptop
computer with minimal assistance from research staff. Two
copies of the report were automatically printed upon assess-
ment completion. Research staff gave one copy to the patient.
They handed the other (physician report) to the office staff who
placed it in the patient’s chart for physician review before and/
or during the appointment.
Outcome Measures
Performance of 5As. Physician 5A performance was measured
via an exit assessment completed by patients. The assessment
contained the following yes/no questions: “Did your doctor...”
“ask whether you smoke?” (Ask), “ask whether you are ready to
Figure 1. Patient and physician recruitment flowcharts.
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you set goals about quitting?” (Assist 1), “give you written
materials about quitting?” (Assist 2), “refer you to a quit-
smoking program?” (Assist 3), “talk to you about quit-smoking
medications?” (Assist 4), and “make a follow-up appointment
to discuss smoking?” (Arrange). These questions have been
previously assessed and found to yield reliable responses in a
prior study of 3,037 adult smokers.
26
Measures of Smoking Behavior. The primary outcome measure
was 7-day point-prevalence abstinence, defined as not smoking
at all in the past 7 days. Secondary smoking outcomes included
longest quit attempt (in days), total number of 24-hour quit
attempts, and stage-of-change progression. Saliva–cotinine
samples were obtained from a 35% subsample of self-reported
quitters. Abstinence was bioverified in 88% (14 of 16) of
samples collected (cotinine <25 ng/ml), consistent with
studies of self-report quit rates.
27 There was no evidence of
differential reporting accuracy between intervention and
control groups based on bioverification. Stage-of-change pro-
gressionwas assessedby examiningthedifferencebetweenbase-
line and 6-month stage.
Statistical Analysis
Based on computer-tailored intervention studies,
11,14 we as-
sumed a 12.5 and 7.5% quit rate in the treatment and control
groups, respectively. For power=0.80 and alpha=0.05, the N
required to detect this low-moderate size group difference is 564.
Descriptive statistics were used to characterize the sample at
baseline. Differences between groups were determined using the
Pearson’s chi-square test for categorical variables and the inde-
pendent sample t test for continuous variables. When differences
were found, these variables were incorporated as covariates into
subsequent outcome analyses. An important element of the
design was nesting of patients within physician practice.
Physician performance of each of the 5As was analyzed
using a hierarchic generalized linear model analysis of vari-
ance, controlling for baseline variables identified as covariates.
Patient 7-day point-prevalence abstinence was analyzed via a
generalized linear model using Logit Link function, with
Figure 2. Sample expert-system report.
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physician as clustering variable, was used to examine longest
quit attempt, number of quit attempts, and stage-of-change
progression.
RESULTS
Sample Characteristics
Physician participants were 83% Caucasians, 13% Asians, and
1% African Americans. The average age of the physicians was
51.1 (SD=8.1); 74% were males. The average years postmedi-
cal school was 24.3 (SD=8.6). Physician specialty was 68%
Internal Medicine and 32% Family Medicine. Four percent of
the physicians were “current smokers”, 67% were “never
smokers”, and 29% were “former smokers”. There were no
differences between physicians randomized to intervention
and control groups on any measured demographic or medical
practice factor.
Patient demographic and smoking characteristics are
presented in Table 1. A majority of patients were Caucasians
and females. Intervention and control groups did not differ
on any demographic variables. Patients smoked an average
of 14 cigarettes daily and reported mild-to-moderate nicotine
dependence. Intervention and control groups differed only on
chronicity of daily smoking: the intervention group had more
smokers with >25–year smoking history. Consequently,
number-of-years smoked was controlled in all smoking
outcome analyses.
Physician 5A Performance
GEE generalized linear modeling indicated that intervention
physicians exceeded controls on “Assess”, “Advise”, “Assist”,
and “Arrange” (p<0.0001) (see Fig. 3). Per patient report, twice
as many intervention as control physicians assessed patients’
readiness to quit smoking (OR 5.06; 95% CI 3.22, 7.95). More
intervention than control physicians advised their patients to
quit smoking (OR 2.79; 95% CI 1.70, 4.59). Two-to-four times
as many intervention as control physicians provided quit-
smoking assistance including: set goals (OR 4.31; 95% CI 2.59,
7.16), provided written materials (OR 5.14; 95% CI 2.60,
10.14), discussed smoking cessation medication (OR 4.72;
95% CI 2.90, 7.68), and referred to a quit-smoking program
(OR 6.48; 95% CI 3.11, 13.49). Finally, intervention physicians
arranged a follow-up to discuss smoking at 5 times the rate of
control physicians (OR 8.14; 95% CI 3.98, 16.68).
Six-Month Smoking Cessation Outcomes
Smoking outcomes are presented in Table 2. Seven-day point-
prevalence abstinence was higher in the intervention group
(12%) than the control group (8%), a difference that ap-
proached, but did not reach significance (OR 1.77; 95% CI 0.94,
3.34, p=.078). Intervention patients surpassed controls on
numberofdaysquitbutnotonnumberof24-hourquitattempts.
Stage-of-change progression was analyzed by creating a
“change” score variable, calculated as the difference between
baseline and 6-month stage scores. Intervention condition was
a significant predictor of “change”, indicating that a larger pro-
Figure 3. Patient-reported “5A” performance by physicians (n=518). Ratings are based on patient exit interviews occurring immediately
postvisit. All group differences, except “Ask”, are statistically significant.
482 Unrod et al.: Smoking Cessation Intervention by Primary Care Physicians JGIMportion of intervention than control patients displayed forward
movement through the stages (F=3.84, df=465, p<0.05).
DISCUSSION
This study tested the effectiveness of a brief computer-tailored
intervention to increase provision of smoking cessation
counseling by physicians and the quit rate among their
patients who smoke. Our primary finding is that physicians
who received the intervention were more likely to perform the
5As. Specifically, the intervention increased the rate at which
physicians advised patients to quit, and more than doubled
the rate at which they assessed readiness to quit, assisted in
quitting, and arranged follow-up. All “assist” and “arrange”
activities, those that have been shown to be most problematic
in terms of physician adherence,
6,8 were significantly in-
creased by the intervention.
Despite the large intervention effect on physician 5A perfor-
mance, 6-month smoking cessation rates were only modestly
higher among patients who received the intervention, an effect
that approached but did not reach statistical significance. The
intervention did result in longer quit attempts, one of the
strongest determinants of cessation success,
28 and greater
stage-of-change forward movement, which have been associ-
ated with enhanced quit attempts.
19 The 12% quit rate
observed among intervention patients is consistent with quit
rates achieved by other interventions in primary care set-
tings.
29–32 However, the control group cessation rate (8%) was
higher than that predicted by secular trends,
33 resulting in a
small between-group difference and treatment effect. One
factor that may have contributed to the relatively high
control-group quit rate is that smokers in the control condition
were exposed to an active treatment ingredient. Namely, as
part of the assessment, patients were asked about their
smoking status and assessed for readiness to quit, which are
two of the 5As. The assessment may have sensitized smokers
in the control group to consider quitting smoking.
Another possible reason for the small cessation effect is the
less than anticipated sample size and consequent reduction in
statistical power to detect group differences. The average
patient caseload per physician was lower than that expected
on the basis of focus groups conducted before study com-
mencement. In addition, the proportion of patients identified
as smokers (15%) was significantly less than the expected 20–
30% found in other primary care studies
29,34 and less than the
estimated 25% smoking prevalence in NYC when the study
was designed. Thus, we did not attain our intended enrollment
target. The low smoking base rate in the current study may
reflect the 11% smoking prevalence decline observed in NYC,
presumably attributable to comprehensive citywide tobacco
control measures that were implemented concurrently.
35
An important limitation of this study is that a minority of
the physicians contacted to participate were enrolled because
a large proportion refused participation or could not be
reached. Although demographic information on nonparticipa-
tors is not available, physicians in the current study may be a
highly select group.
Even though the intervention had only a modest effect on
smoking behaviors, the innovative integration of computer
technology during routine medical visits was highly effective in
enhancing 5A adherence. In its impact on physicians’ behavior,
the current intervention compares favorably to other primary
care interventions.
29,31,34,36,37 For instance, it produced more
comprehensive improvements in 5A performance than interven-
tionsthatfeatured a vital sign stamp
34 ora smokingassessment
questionnaire only.
29 It also produced greater gains in “Advise”
and “Assist” compared to a significantly more intensive, five-
component intervention that included a physician tutorial, vital
sign stamp, physician performance feedback, nicotine replace-
ment therapy, and telephone counseling.
31 Smoking outcomes
with the current intervention were also comparable to an
intervention consisting of training physicians in brief cessation
counseling.
36 Cessation rates surpassed those of an interven-
tion consisting of a 2-hour tutorial plus prompt.
37 Because 70%
of U.S. smokers visit their physician annually, even modest
cessation rates can translate into significant public health
benefit. Although other public health approaches, such as
telephone quitlines, are available, physician advice and referral
are important to maximize use of these resources.
38,39
Another important aspect of this intervention is the minimal
time burden and staff resources needed for implementation.
Intervention physicians spent an average of 3.8 minutes dis-
cussing smoking. Minimal burden increases the likelihood of
integration into a busy clinical practice. The main requirements
for integration are availability of a patient-accessible computer
with printer and encouragement of all smokers to complete the
assessment before their physician visit. Incorporating comput-
er-tailored programs into routine medical practice can be
challenging. The current intervention addressed some previ-
ously identified barriers
40 by streamlining administration time
and directly targeting patients who were current smokers.
Table 2. Smoking Cessation Outcomes 6 Months Postintervention:
Outcome Measure Intervention
(n=237)
Control
(n=228)
p-Value
7-Day point-prevalence
abstinence
12% 8% 0.078
Longest quit attempt
in days: M (SD)
18.4 (36.7) 12.4 (29.6) 0.05
Number of 24-hour quit
attempts: M (SD)
2.1 (3.4) 2.1 (3.5) 0.91
Table 1. Baseline Characteristics of Study Participants
Intervention (n=270) Control (n=248)
Age: M (SD) 43.5 (14.7) 42.8 (14.2)
Gender: % ♀ 58 64
Race (%):
Caucasian 61 63
African American 20 20
Other 19 17
Hispanic (%) 15 19
Education: % BA+ 32 37
No. of cigs./day: M (SD) 13.3 (8.7) 14.4 (9.9)
Fagerstrom: M (SD) 3.5 (2.7) 3.8 (2.6)
Smoked daily: % ≤25 years 64.4 71.0*, p<0.05
% >25 years 35.6 29.0*, p<0.05
Longest quit attempt
% ≤1 month 58.5 50.2
% >1 month 41.5 49.8
Stages of change (%)
Precontemplation 5.6 8.5
Contemplation 53.7 50.0
Preparation 40.7 41.5
*Statistically significant difference between the groups.
483 Unrod et al.: Smoking Cessation Intervention by Primary Care Physicians JGIMResearch staff recruited patients into the current study. Al-
though this practice helped to reduce demand on office staff, it
diminished the number of smokers that could be reached and
the possibility of readministering the intervention to returning
smokers, both of which may enhance intervention impact. A
manuscript describing cost effectiveness of the intervention is
currently under review.
The current study shows that a brief computer-tailored
intervention can significantly increase primary care physi-
cians’ implementation of the 5As and result in modest effects
on smoking outcomes. This intervention holds promise in
reaching the main objective of the Smoking Cessation Clinical
Practice Guideline: to intervene with all smokers who visit their
physician. Increased rates of guideline implementation can
potentially have an enormous public health impact. Further
research is needed to increase the potency of the intervention
with regard to quit rates and to determine how best to integrate
it into outpatient health care settings.
Acknowledgement: The authors thank and acknowledge Shannon
Erisman and Quinne Leyden for their contributions in data
collection.
Potential Financial Conflicts of Interest: None disclosed.
Corresponding Author: Marina Unrod, PhD; Tobacco Research &
Intervention Program, H. Lee Moffitt Cancer Center & Research
Institute, 4115 E. Fowler Ave., Tampa, FL 33617, USA (e-mail:
unrodm@moffitt.usf.edu).
REFERENCES
1. Centers for Disease Control and Prevention. Annual smoking—attribut-
able mortality, years of potential life lost, and productivity losses—United
States, 1997–2001. MMWR Morb Mortal Wkly Rep. 2005;54:625–8.
2. Fiore M, Bailey W, Cohen S, et al. Treating Tobacco Use and
Dependence. Clinical Practice Guideline. Rockville MD: U.S. Department
of Health and Human Services, U.S. Public Health Service; 2000.
3. Davis RM. Uniting physicians against smoking: the need for a coordi-
nated national strategy. J Am Med Assoc 1988;259:2900–1.
4. Fiore MC, Jorenby DE, Schensky AE, Smith SS, Bauer RR, Baker TB.
Smoking status as the new vital sign: effect on assessment and
intervention in patients who smoke. Mayo Clin Proc 1995;70(3):209–13.
5. Gorin SS, Heck JE. Meta-analysis of the efficacy of tobacco counseling
by health care providers. Cancer Epidemiol Biomark Prev 2004;13
(12):2012–22.
6. Thorndike AN, Rigotti NA, Stafford RS, Singer DE. National patterns
in the treatment of smokers by physicians. JAMA 1998;279:604–8.
7. Doescher MP, Saver BG. Physicians’ advice to quit smoking: the glass
remains half empty. J Fam Pract 2000;49:543–7.
8. Ellerbeck EF, Ahluwalia JS, Jolicoeur DG, Gladden J, Mosier MC.
Direct observation of smoking cessation activities in primary care
practice. J Fam Pract 2001;50:688–93.
9. Gilpin EA, Pierce JP, Johnson M, Bal D. Physicians advice to quit
smoking: results from the 1990 California Tobacco Survey. J Gen Intern
Med 1993;8:549–53.
10. Goldstein MG, Niaura R, Willey-Lessner C, et al. Physicians counseling
smokers. Arch Intern Med 1997;157:1313–9.
11. Prochaska JO, DiClemente CC, Velicer WF, Rossi JS. Standardized,
individualized, interactive and personalized self-help programs for
smoking cessation. Health Psychol 1993;12:399–405.
12. Prochaska JO, Velicer WF, Fava JL, Rossi JS, Tsoh JY. Evaluating a
population-based recruitment approach and a stage-based expert system
intervention for smoking cessation. Addict Behav 2001;26(4):583–602.
13. Prochaska JO, Velicer WF, Redding C, et al. Stage-based expert
systems to guide a population of primary care patients to quit smoking,
eat healthier, prevent skin cancer, and receive regular mammograms.
Prev Med 2005;41(2):406–16.
14. Strecher VJ, Kreuter M, Den Boer DJ, Kobrin S, Hospers HJ, Skinner
CS. The effects of computer-tailored smoking cessation messages in
family practice settings. J Fam Pract 1994;39(3):262–70.
15. Strecher VJ, Shiffman S, West R. Randomized controlled trial of a web-
based computer-tailored smoking cessation program as a supplement to
nicotine patch therapy. Addiction 2005;100(5):682–8.
16. Dijkstra A, De Vries H, Roijackers J. Long-term effectiveness of
computer-generated tailored feedback in smoking cessation. Health
Educ Res 1998;13(2):207–14.
17. Dijkstra A, De Vries H, Roijackers J, van Breukelen G. Tailored
interventions to communicate stage-matched information to smokers in
different motivational stages. J Consult Clin Psychol. 1998;66(3):549–
57.
18. Biener L, Abrams DD. The Contemplation Ladder: validation of a
measure of readiness to consider smoking cessation. Health Psychol
1991;10:360–5.
19. Abrams DB, Biener L. Motivational characteristics of smokers at the
workplace: a public health challenge. Prev Med 1992;21:679–87.
20. Prochaska JO, DiClemente CC. Stages and processes of self-change of
smoking: toward an integrative model of change. J Consult Clin Psychol
1983;51:390–5.
21. Heatherton TF, Kozlowski LT, Frecker RC, Fagerstrom KO. The
Fagerstrom test for nicotine dependence: a revision of the Fagerstrom
tolerance questionnaire. Br J Addict 1991;86(9):1119–27.
22. Pomerleau CS, Carton SM, Lutzke ML, Flessland KA, Pomerleau OF.
Reliability of the Fagerstrom tolerance questionnaire and the Fagerstrom
test for nicotine dependence. Addict Behav 1994;19(1):33–9.
23. Dijkstra A, DeVries H, Bakker M. Pros and cons of quitting, self-
efficacy, and the stages of change in smoking cessation. J Consult Clin
Psychol 1996;64:758–63.
24. Velicer WF, DiClemente CC, Rossi JS, Prochaska JO.R e l a p s e
situations and self-efficacy: an integrative model. Addict Behav
1990;15:271–83.
25. Soumerai SB, Avorn J. Principles of educational outreach (‘academic
detailing’) to improve clinical decision making. JAMA 1990;263:549–56.
26. Goldstein MG, Niaura R, Willey-Lessner C, et al. Physicians counseling
smokers. Arch Intern Med 1997;157:1313–19.
27. Wadland WC, Stoffelmayr B, Ellen E, Crombach A, Ives K. Enhancing
smoking cessation rates in primary care. J Fam Pract 1999;48(9):711–8.
28. Farkas A, Pierce J, Gilpin E, et al. Is stage of change a useful measure
of the likelihood of smoking cessation? Annals Behav Med 1996;18
(2):79–86.
29. Milch CE, Edmunson JM, Beshansky JR, Griffith JL, Selker HP.
Smoking cessation in primary care: a clinical effectiveness trial of two
simple interventions. Prev Med 2004;38(3):284–94.
30. Fiore MC, McCarthy DE, Jackson TC, et al. Integrating smoking
cessation treatment into primary care: an effectiveness study. Prev Med
2004;38(4):412–20.
31. Katz DA, Muehlenbruch DR, Brown RL, Fiore MC, Baker TB; AHRQ
Smoking Cessation Guideline Study Group. Effectiveness of imple-
menting the agency for healthcare research and quality smoking
cessation clinical practice guideline: a randomized, controlled trial. J
Natl Cancer Inst 2004;96(8):594–603.
32. Lancaster T, Stead L. Physician advice for smoking cessation. Cochrane
Database Syst Rev 2004;18(4):CD000165.
33. Hughes JR, Keely J, Naud S. Shape of the relapse curve and long-term
abstinence among untreated smokers. Addiction 2004;99:29–38.
34. Ahluwalia JS, Gibson CA, Kenney E, Wallace DD, Resnicow K.
Smoking status as a vital sign. J Gen Intern Med 1999;14:402–8.
35. Frieden TR, Mostashari F, Kerker BD, Miller N, Hajat A, Frankel M.
Adult tobacco use levels after intensive tobacco control measures: New
York City, 2002–2003. Am J Public Health 2005;95(6):1016–23.
36. Ockene JK, Kristeller J, Goldberg R, et al. Increasing the efficacy of
physician-delivered smoking interventions: a randomized clinical trial. J
Gen Intern Med 1991;6(1):1–8.
37. Stretcher VJ, O’Malley MS, Villagra VG, et al. Can residents be trained
to counsel patients about quitting smoking? Results from a randomized
trial. J Gen Intern Med 1991;6(1):9–17.
38. Ossip-Klein DJ, McIntosh S. Quitlines in North America: evidence base
and applications. Am J Med Sci 2003;326(4):201–5.
39. Zwar NA, Richmond RL. Role of the general practitioner in smoking
cessation. Drug Alcohol Rev 2006;25(1):21–6.
40. Sciamanna CN, Marcus BH, Goldstein MG, et al. Feasibility of
incorporating computer-tailored health behaviour communications in
primary care settings. Informatics in Primary Care. 2004;12:40–8.
484 Unrod et al.: Smoking Cessation Intervention by Primary Care Physicians JGIM